15-year experience with rotavirus vaccination in Mexico: a systematic literature review

References

• Walker CL, Aryee MJ, Boschi-Pinto C, Black RE. Estimating diarrhea mortality among young children in low and middle income countries. PLoS One. 2012;7:e29151. doi:10.1371/journal.pone.0029151.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Diarrhoeal disease: fact sheet. 2017; [accessed 2020 Nov 6]. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease.
   Google Scholar
• World Health Organization. Diarrhea: why children are still dying and what can be done. Geneva. 2009; [accessed 2020 Nov 6]. https://apps.who.int/iris/bitstream/handle/10665/44174/9789241598415_eng.pdf;jsessionid=E855D6F11A7121F159AD3467672D2BD2?sequence=1.
   Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. World Health Organization-coordinated global rotavirus surveillance N. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000-2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013.
   PubMed Web of Science ®Google Scholar
• Steele AD, Victor JC, Carey ME, Tate JE, Atherly DE, Pecenka C, Diaz Z, Parashar UD, Kirkwood CD. Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? Hum Vaccin Immunother. 2019;15:1215–27. doi:10.1080/21645515.2018.1553593.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines. WHO position paper January 2013. Weekly Epidemiol Rec. 2013;88:49–64.
   PubMedGoogle Scholar
• Black R, Fontaine O, Lamberti L, Bhan M, Huicho L, El Arifeen S, Masanja H, Walker CF, Mengestu TK, Pearson L, et al. Drivers of the reduction in childhood diarrhea mortality 1980-2015 and interventions to eliminate preventable diarrhea deaths by 2030. J Glob Health. 2019;9:020801. doi:10.7189/jogh.09.020801.
   PubMed Web of Science ®Google Scholar
• Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172:958–65. doi:10.1001/jamapediatrics.2018.1960.
   PubMed Web of Science ®Google Scholar
• de Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines. 2008;7:345–53. doi:10.1586/14760584.7.3.345.
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization. About Rotavirus. [accessed 2020 June 21]. https://www.paho.org/hq/index.php?option=com_content&view=article&id=1861:2009-about-rotavirus&Itemid=1621&lang=en.
   Google Scholar
• Perez Schael I, O’Ryan M, Sáez-Llorens X, Linhares AC, Velázquez FR, Colindres RE, Breuer T, Ortega-Barria E. Clinical development, registration, and introduction of human rotavirus vaccine: the Latin American experience. Trials in Vaccinology. 2012;1:10–20. doi:10.1016/j.trivac.2012.01.001.
   Google Scholar
• Oliveira L, Camacho LAB, Coutinho ESF, Ruiz-Matus C, Leite JPG. Rotavirus vaccine effectiveness in Latin American and Caribbean countries: a systematic review and meta-analysis. Vaccine. 2015;33:A248–A254. doi:10.1016/j.vaccine.2014.11.060.
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect. 2012;18(Suppl 5):57–63. doi:10.1111/j.1469-0691.2012.03981.x.
   PubMed Web of Science ®Google Scholar
• Luna-Casas G, Juliao P, Carreño-Manjarrez R, Castañeda-Prado A, Cervantes-Apolinar MY, Navarro-Rodriguez R, Sánchez-González G, Cortés-Alcalá R, DeAntonio R. Vaccine coverage and compliance in Mexico with the two-dose and three-dose rotavirus vaccines. Hum Vaccin Immunother. 2019;15:1251–59. doi:10.1080/21645515.2018.1540827.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269, W264. doi:10.7326/0003-4819-151-4-200908180-00135.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–49. doi:10.1016/j.jclinepi.2007.11.008.
   PubMed Web of Science ®Google Scholar
• Fowkes FG, Fulton PM. Critical appraisal of published research: introductory guidelines. BMJ. 1991;302:1136–40. doi:10.1136/bmj.302.6785.1136.
   PubMed Web of Science ®Google Scholar
• Sanderson S, Tatt ID, Higgins JP. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007;36:666–76. doi:10.1093/ije/dym018.
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S, (editors). Cochrane handbook for systematic reviews of interventions. Version 5.0.2. The Cochrane Collaboration; 2008.
   Google Scholar
• Cochrane Effective Practice and Organisation of Care (EPOC). EPOC resources for review authors. EPOC Resources. 2017; [accessed 2020 Sept 29]; epoc.cochrane.org/resources/epoc-resources-review-authors.
   Google Scholar
• Baay M, Bollaerts K, Struchiner C, Verstraeten T. Background rates of disease in Latin American children from a rotavirus vaccine study. Hum Vaccin Immunother. 2017;13:1916–20. doi:10.1080/21645515.2017.1320007.
   PubMed Web of Science ®Google Scholar
• Carlos F, Gomez JA, Anaya P, Standaert B, Carreño-Manjarrez R. Health economics assessment of rotavirus vaccines in Mexico. Value Health. 2013;16:A72. doi:10.1016/j.jval.2013.03.324.
   Web of Science ®Google Scholar
• Ciarlet M, Sani-Grosso R, Yuan G, Liu GF, Heaton PM, Gottesdiener KM, Arredondo JL, Schodel F. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Pediatr Infect Dis J. 2008;27:874–80. doi:10.1097/INF.0b013e3181782780.
   PubMed Web of Science ®Google Scholar
• Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y. Economic impact of a rotavirus vaccination program in Mexico. Rev Panam Salud Publica. 2009;25:481–90. doi:10.1590/S1020-49892009000600003.
   PubMed Web of Science ®Google Scholar
• Esparza-Aguilar M, Bautista-Márquez A, MdC G-A, Richardson-López-Collada VL. Mortalidad por enfermedad diarreica en menores, antes y después de la introducción de la vacuna contra el rotavirus. Salud publica de Mexico. Salud Publica Mex. 2009;51:285–90. doi:10.1590/S0036-36342009000400004.
   PubMed Web of Science ®Google Scholar
• Gastañaduy PA, Sánchez-Uribe E, Esparza-Aguilar M, Desai R, Parashar UD, Patel M, Richardson V. Effect of rotavirus vaccine on diarrhea mortality in different socioeconomic regions of Mexico. Pediatrics. 2013;131:e1115–1120. doi:10.1542/peds.2012-2797.
   PubMed Web of Science ®Google Scholar
• Granados-García V, Velázquez FR, Salmerón J, Homedes N, Salinas-Escudero G, Morales-Cisneros G. Burden of disease and costs of treating rotavirus diarrhea in Mexican children for the period 2001-2006. Vaccine. 2011;29:6712–19. doi:10.1016/j.vaccine.2011.03.020.
   PubMed Web of Science ®Google Scholar
• Leboreiro JI, Zapata IB, Montessoro GM, Aguilar CEL, Macías MER. Anti-rotavirus vaccination and the demand for hospital care of children with diarrhea. Rev Mex Pediatr. 2013;80:15–21.
   Google Scholar
• Linhares AC, Macias-Parra M, Sáez-Llorens X, Vergara R, Jimenez E, Raúl Velázquez F, Cervantes Y, Abate HJ, Rivera L, Ruttimann R, et al. Rotavirus gastroenteritis in Latin America: a hospital-based study in children under 3 years of age. Trials in Vaccinology. 2012;1:36–41. doi:10.1016/j.trivac.2012.07.002.
   Google Scholar
• Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, Lopez P, Macias-Parra M, Ortega-Barria E, Rivera-Medina DM, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371:1181–89. doi:10.1016/S0140-6736(08)60524-3.
   PubMed Web of Science ®Google Scholar
• Paternina-Caicedo A, Parashar UD, Alvis-Guzman N, De Oliveira LH, Castano-Zuluaga A, Cotes-Cantillo K, Gamboa-Garay O, Coronell-Rodriguez W, De la Hoz-Restrepo F. Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries. Vaccine. 2015;33:3923–28. doi:10.1016/j.vaccine.2015.06.058.
   PubMed Web of Science ®Google Scholar
• Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico. Pediatr Infect Dis J. 2011;30:S11–15. doi:10.1097/INF.0b013e3181fefb32.
   PubMed Web of Science ®Google Scholar
• Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica. 2007;21:205–16. doi:10.1590/S1020-49892007000300003.
   PubMed Web of Science ®Google Scholar
• Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299–305. doi:10.1056/NEJMoa0905211.
   PubMed Web of Science ®Google Scholar
• Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med. 2011;365:772–73. doi:10.1056/NEJMc1100062.
   PubMed Web of Science ®Google Scholar
• Richardson-López Collada V, Bautista-Márquez A, Sánchez-Uribe E, Esparza-Aguilar M. [Population impact of rotavirus vaccination in Mexico after 10 years]. Salud Publica Mex. 2020;62:6–13. doi:10.21149/9936.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics. 2007;120:e253–261. doi:10.1542/peds.2006-2630.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. doi:10.1056/NEJMoa052434.
   PubMed Web of Science ®Google Scholar
• Salinas B, Perez Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarzabal JP, Cervantes Y, Costa Clemens S, Damaso S, Hardt K, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24:807–16. doi:10.1097/01.inf.0000178294.13954.a1.
   PubMed Web of Science ®Google Scholar
• Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis. 2008;8:103. doi:10.1186/1471-2334-8-103.
   PubMed Web of Science ®Google Scholar
• Velázquez FR, Colindres RE, Grajales C, Hernández MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J. 2012;31:736–44. doi:10.1097/INF.0b013e318253add3.
   PubMed Web of Science ®Google Scholar
• Yen C, Figueroa JR, Uribe ES, Carmen-Hernández LD, Tate JE, Parashar UD, Patel MM, Richardson López-Collado V. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis. 2011;204:783–86. doi:10.1093/infdis/jir390.
   PubMed Web of Science ®Google Scholar
• Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364:2283–92. doi:10.1056/NEJMoa1012952.
   PubMed Web of Science ®Google Scholar
• Bayard V, DeAntonio R, Contreras R, Tinajero O, Castrejon MM, Ortega-Barria E, Colindres RE. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama. Int J Infect Dis. 2012;16:e94–98. doi:10.1016/j.ijid.2011.09.003.
   PubMed Web of Science ®Google Scholar
• Santos VS, Berezin EN, Gurgel RQ. Rotavirus in Latin America: current situation and perspectives. J Pediatric Infect Dis Soc. 2017;6:1–2. doi:10.1093/jpids/piw071.
   PubMed Web of Science ®Google Scholar
• Felix-Valenzuela L, Cooley-García DP, Cano-Rangel MA, Durazo-Arvizu MA, Mata-Haro V. Predominance of G9P[4] Rotavirus from Children with Acute Gastroenteritis in Northwestern Mexico. Intervirology. 2016;59:228–33. doi:10.1159/000464132.
   PubMed Web of Science ®Google Scholar
• Velazquez RF, Linhares AC, Munoz S, Seron P, Lorca P, DeAntonio R, Ortega-Barria E. Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. BMC Pediatr. 2017;17:14. doi:10.1186/s12887-016-0771-y.
   PubMed Web of Science ®Google Scholar
• Debellut F, Clark A, Pecenka C, Tate J, Baral R, Sanderson C, Parashar U, Kallen L, Atherly D. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study. The Lancet Global Health. 2019;7:e1664–e1674. doi:10.1016/S2214-109X(19)30439-5.
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization. PAHO revolving fund. [accessed 2020 Jun 21]. https://www.paho.org/en/resources/paho-revolving-fund#:~:text=The%20PAHO%20Revolving%20Fund%20is,in%20the%20annals%20of%20vaccination.&text=Through%20the%20fund%2C%2041%20countries,populations%20at%20the%20lowest%20price.
   Google Scholar
• World Health Organization. WHO prequalifies new rotavirus vaccine. [accessed 2020 Nov 6]. https://www.who.int/medicines/news/2018/prequalified_new-rotavirus_vaccine/en/. Geneva, 2018.
   Google Scholar
• Burnett E, Parashar U, Tate J. Rotavirus vaccines: effectiveness, safety, and future directions. Paediatr Drugs. 2018;20:223–33. doi:10.1007/s40272-018-0283-3.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. The Lancet. 2014;383:2136–43. doi:10.1016/S0140-6736(13)62630-6.
   PubMed Web of Science ®Google Scholar
• Isanaka S, Guindo O, Langendorf C, Matar Seck A, Plikaytis BD, Sayinzoga-Makombe N, McNeal MM, Meyer N, Adehossi E, Djibo A, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in niger. N Engl J Med. 2017;376:1121–30. doi:10.1056/NEJMoa1609462.
   PubMed Web of Science ®Google Scholar
• Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, Kumar D, Kanungo S, Kamat V, Kang G, et al. A randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35:6228–37. doi:10.1016/j.vaccine.2017.09.014.
   PubMed Web of Science ®Google Scholar